RNA Editing by ADAR Adenosine Deaminases: From Molecular Plasticity of Neural Proteins to the Mechanisms of Human Cancer

被引:0
作者
A. O. Goncharov
A. A. Kliuchnikova
S. S. Nasaev
S. A. Moshkovskii
机构
[1] Institute of Biomedical Chemistry,
[2] Pirogov Russian National Research Medical University,undefined
来源
Biochemistry (Moscow) | 2019年 / 84卷
关键词
adenosine deaminase; RNA editing; ADAR; cancer; immunity; neoantigen;
D O I
暂无
中图分类号
学科分类号
摘要
RNA editing by adenosine deaminases of the ADAR family attracts a growing interest of researchers, both zoologists studying ecological and evolutionary plasticity of invertebrates and medical biochemists focusing on the mechanisms of cancer and other human diseases. These enzymes deaminate adenosine residues in the double-stranded (ds) regions of RNA with the formation of inosine. As a result, some RNAs change their three-dimensional structure and functions. Adenosine-to-inosine editing in the mRNA coding sequences may cause amino acid substitutions in the encoded proteins. Here, we reviewed current concepts on the functions of two active ADAR isoforms identified in mammals (including humans). The ADAR1 protein, which acts non-specifically on extended dsRNA regions, is capable of immunosuppression via inactivation of the dsRNA interactions with specific sensors inducing the cell immunity. Expression of a specific ADAR1 splicing variant is regulated by the type I interferons by the negative feedback mechanism. It was shown that immunosuppressing effects of ADAR1 facilitate progression of some types of cancer. On the other hand, changes in the amino acid sequences resulting from the mRNA editing by the ADAR enzymes can result in the formation of neoantigens that can activate the antitumor immunity. The ADAR2 isoform acts on RNA more selectively; its function is associated with the editing of mRNA coding regions and can lead to the amino acid substitutions, in particular, those essential for the proper functioning of some neurotransmitter receptors in the central nervous system.
引用
收藏
页码:896 / 904
页数:8
相关论文
共 449 条
  • [1] Lobas A A(2018)Proteogenomics of malignant melanoma cell lines: the effect of stringency of exome data filtering on variant peptide identification in shotgun proteomics J. Proteome Res. 17 1801-1811
  • [2] Pyatnitskiy M A(2018)Proteogenomics of adenosine-to-inosine RNA editing in the fruit fly J. Proteome Res. 17 3889-3903
  • [3] Chernobrovkin A L(2019)Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade Nature 565 43-48
  • [4] Ilina I Y(2017)ADAR1 restricts LINE-1 retrotransposition Nucleic Acids Res. 45 155-168
  • [5] Karpov D S(2002)RNA editing by adenosine deaminases that act on RNA Annu. Rev. Biochem. 71 817-846
  • [6] Solovyeva E M(1994)Purification of the Xenopus laevis double-stranded RNA adenosine deaminase J. Biol. Chem. 269 9933-9939
  • [7] Kuznetsova K G(2009)Origins and evolution of ADAR-mediated RNA editing IUBMB Life 61 572-578
  • [8] Ivanov M V(2000)dADAR, a RNA 6 1004-1018
  • [9] Lyssuk E Y(1996) double-stranded RNA-specific adenosine deaminase is highly developmentally regulated and is itself a target for RNA editing J. Biol. Chem. 271 31795-31798
  • [10] Kliuchnikova A A(2017)RED2, a brain-specific member of the RNA-specific adenosine deaminase family J. Biol. Chem. 292 4326-4335